K.W. Dungan

657 total citations
23 papers, 505 citations indexed

About

K.W. Dungan is a scholar working on Physiology, Organic Chemistry and Surgery. According to data from OpenAlex, K.W. Dungan has authored 23 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Physiology, 4 papers in Organic Chemistry and 3 papers in Surgery. Recurrent topics in K.W. Dungan's work include Pharmacological Effects and Assays (3 papers), Nitric Oxide and Endothelin Effects (2 papers) and Veterinary Pharmacology and Anesthesia (2 papers). K.W. Dungan is often cited by papers focused on Pharmacological Effects and Assays (3 papers), Nitric Oxide and Endothelin Effects (2 papers) and Veterinary Pharmacology and Anesthesia (2 papers). K.W. Dungan collaborates with scholars based in United States and Germany. K.W. Dungan's co-authors include P.M. Lish, John H. Weikel, R.J. Seidehamel, H.C. Stanton, Allen W. Gomoll, Elizabeth Gillespie, D. Alfred Owens, Davis L. Temple, Joseph P. Yevich and Domingo M. Aviado and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Biochemical Pharmacology.

In The Last Decade

K.W. Dungan

23 papers receiving 437 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K.W. Dungan United States 12 171 138 78 76 61 23 505
L. H. Smith United States 10 213 1.2× 171 1.2× 88 1.1× 76 1.0× 64 1.0× 29 637
J. S. Stephenson United Kingdom 6 132 0.8× 140 1.0× 51 0.7× 57 0.8× 52 0.9× 8 463
G. Kuschinsky Germany 15 275 1.6× 135 1.0× 50 0.6× 80 1.1× 77 1.3× 99 751
Allen W. Gomoll United States 12 165 1.0× 257 1.9× 50 0.6× 49 0.6× 45 0.7× 38 558
C Labrid France 12 204 1.2× 180 1.3× 38 0.5× 88 1.2× 49 0.8× 35 510
Franklin E. Roth United States 13 130 0.8× 74 0.5× 88 1.1× 52 0.7× 84 1.4× 22 501
A. M. Simonis Netherlands 10 258 1.5× 45 0.3× 54 0.7× 142 1.9× 90 1.5× 18 545
Morton E. Goldberg United States 9 218 1.3× 149 1.1× 38 0.5× 140 1.8× 51 0.8× 15 584
E. Winslow United Kingdom 13 345 2.0× 330 2.4× 114 1.5× 64 0.8× 58 1.0× 43 611
Roy Jordan United Kingdom 9 171 1.0× 109 0.8× 61 0.8× 27 0.4× 106 1.7× 12 382

Countries citing papers authored by K.W. Dungan

Since Specialization
Citations

This map shows the geographic impact of K.W. Dungan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K.W. Dungan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K.W. Dungan more than expected).

Fields of papers citing papers by K.W. Dungan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K.W. Dungan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K.W. Dungan. The network helps show where K.W. Dungan may publish in the future.

Co-authorship network of co-authors of K.W. Dungan

This figure shows the co-authorship network connecting the top 25 collaborators of K.W. Dungan. A scholar is included among the top collaborators of K.W. Dungan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K.W. Dungan. K.W. Dungan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chrousos, George, K.W. Dungan, Feingold Kr, et al.. (2000). Abnormalities of Female Pubertal Development -- Endotext. 1 indexed citations
2.
Chrousos, George P., K.W. Dungan, Feingold Kr, et al.. (2000). Cholesterol Lowering Drugs -- Endotext. 4 indexed citations
3.
Stanton, H.C. & K.W. Dungan. (1986). In vitro effects of beta adrenoceptor agonists and antagonists on the rat ovarian suspensory ligament.. Journal of Pharmacology and Experimental Therapeutics. 239(2). 591–596. 7 indexed citations
4.
Gillespie, Elizabeth, K.W. Dungan, Allen W. Gomoll, & R.J. Seidehamel. (1985). Selected immunologic properties of tiprinast, a non-steroidal antiallergy agent. International Journal of Immunopharmacology. 7(5). 655–660. 26 indexed citations
5.
Yevich, Joseph P., et al.. (1982). Antiallergics: 3-(1H-tetrazol-5-yl)-4H-pyrimido[2,1-b]benzothiazol-4-ones. Journal of Medicinal Chemistry. 25(7). 864–868. 29 indexed citations
6.
Temple, Davis L., Joseph P. Yevich, John D. Catt, et al.. (1980). Substituted 6,7-dihydroimidazo[1,2-a]purin-9(4H)-ones. Journal of Medicinal Chemistry. 23(11). 1188–1198. 13 indexed citations
7.
Seidehamel, R.J., K.W. Dungan, & Theresa E. Hickey. (1975). Specific Hypotensive and Antihypertensive Ocular Effects of D-Isoproterenol in Rabbits. American Journal of Ophthalmology. 79(6). 1018–1025. 13 indexed citations
8.
Amer, M. Samir, et al.. (1974). THE EFFECTS OF ISOXSUPRINE HYDROCHLORIDE ON THE CYCLIC NUCLEOTIDE SYSTEM IN THE RAT UTERUS. Journal of Pharmacology and Experimental Therapeutics. 190(2). 243–248. 3 indexed citations
9.
Seidehamel, R.J. & K.W. Dungan. (1974). Characteristics and pharmacologic utility of an intraocular pressure (IOP) model in unanesthetized rabbits.. PubMed. 13(4). 319–22. 19 indexed citations
10.
Dungan, K.W., et al.. (1968). PHARMACOLOGIC POTENCY AND SELECTIVITY OF A NEW BRONCHODILATOR AGENT: SOTERENOL (MJ 1992). Journal of Pharmacology and Experimental Therapeutics. 164(2). 290–301. 23 indexed citations
11.
Lish, P.M., et al.. (1968). MODE OF THE BRONCHODILATOR ACTION OF PHENTOLAMINE. Journal of Pharmacology and Experimental Therapeutics. 163(1). 11–16. 6 indexed citations
12.
Gould, William A., et al.. (1967). Sulfonanilides. II. Analogs of Catecholamines. Journal of Medicinal Chemistry. 10(3). 462–472. 25 indexed citations
13.
Lish, P.M., John H. Weikel, & K.W. Dungan. (1965). Pharmacological and toxicological properties of two new beta-adrenergic receptor antagonists.. PubMed. 149(2). 161–73. 183 indexed citations
14.
Lish, P.M., John H. Weikel, & K.W. Dungan. (1965). PHARMACOLOGICAL AND TOXICOLOGICAL PROPERTIES OF TWO NEW β-ADRENERGIC RECEPTOR ANTAGONISTS. Journal of Pharmacology and Experimental Therapeutics. 149(2). 161–173. 46 indexed citations
15.
Dungan, K.W., H.C. Stanton, & P.M. Lish. (1965). Amidephrine-I: Pharmacologic characterization of a sympathomimetic alkylsulfonamidophenethanolamine. International Journal of Neuropharmacology. 4(4). 219–234. 18 indexed citations
16.
Stanton, H.C., K.W. Dungan, & P.M. Lish. (1965). Amidephrine-II: Cardiovascular actions of a new sympathomimetic amine. International Journal of Neuropharmacology. 4(4). 235–244. 10 indexed citations
17.
Lish, P.M., et al.. (1961). 396 Pharmacological Differentiation of Phenethylamines Commonly Conceived to Have the Same Modes of Action. Biochemical Pharmacology. 8(1). 118–118. 3 indexed citations
18.
Lish, P.M., et al.. (1960). A SURVEY OF THE EFFECTS OF ISOXSUPRINE ON NONVASCULAR SMOOTH MUSCLE. Journal of Pharmacology and Experimental Therapeutics. 129(2). 191–199. 20 indexed citations
19.
Lish, P.M., et al.. (1960). THE UTERINE RELAXANT PROPERTIES OF ISOXSUPRINE. Journal of Pharmacology and Experimental Therapeutics. 129(4). 438–444. 29 indexed citations
20.
Lish, P.M. & K.W. Dungan. (1958). Peristaltic-Stimulating and Fecal-Hydrating Properties of Dioctyl Sodium Sulfosuccinate, Danthron, and Cascara Extracts in the Mouse and Rat**Mead Johnson Research Laboratories, Evansville, Ind.. Journal of the American Pharmaceutical Association (Scientific ed ). 47(5). 371–375. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by L. H. Smith Breakdown of academic impact, for papers by J. S. Stephenson Breakdown of academic impact, for papers by G. Kuschinsky Breakdown of academic impact, for papers by Allen W. Gomoll Breakdown of academic impact, for papers by C Labrid Breakdown of academic impact, for papers by Franklin E. Roth Breakdown of academic impact, for papers by A. M. Simonis Breakdown of academic impact, for papers by Morton E. Goldberg Breakdown of academic impact, for papers by E. Winslow Breakdown of academic impact, for papers by Roy Jordan
Rankless by CCL
2026